Last edition
News about "CAR T-cell therapy "
A large-scale study involving more than 6,800 lymphoma patients found that CAR T-cell therapy delivered at non-FACT accredited centres achieved outcomes comparable to accredited facilities, supporting efforts to expand access to advanced cancer treatments closer to patients’ homes.
CAR T-cell Therapy | 30/05/2026 | By News Bureau
The Lupus Research Alliance and Genentech announce inaugural recipients of the Immune Resetting Therapies for Lupus Award to accelerate research into CAR-T cell therapies for severe lupus patients.
CAR-T Cell Therapy | 28/05/2026 | By News Bureau | 102
Gilead Sciences and Kite Pharma to present new ASCO and EHA 2026 data highlighting progress in Antibody Drug Conjugates (ADCs) and CAR T-cell therapies, including updates on Trodelvy and anito-cel for difficult-to-treat cancers.
CAR T-cell Therapy | 22/05/2026 | By News Bureau | 510
TDB-DST Backs Helix Cell Therapeutics for CAR-T Therapy against Multiple Myeloma
Technology Development Board (TDB) supports Helix Cell Therapeutics and Biocell Innovations in developing dual-targeting CAR-T cell therapy for multiple myeloma under an Indo-Singapore collaboration.
CAR-T Cell Therapy | 14/05/2026 | By News Bureau | 115
Gilead Sciences Completes Arcellx Inc. Acquisition Ahead of Anito-cel Launch
Under the terms of the transaction, Gilead acquired Arcellx for USD 115 per share in cash, plus one non?transferable Contingent Value Right (CVR) of USD 5 per share, representing a total implied equity value of approximately USD 7.8 billion at the time of closing.
CAR T-cell Therapy | 29/04/2026 | By News Bureau | 104
IASO Biotechnology Partners with Instituto Butantan to Localise CAR-T Therapy in Brazil
IASO Bio licenses CAR-T technology to Instituto Butantan for local development in Brazil, aiming to reduce treatment costs and expand public access to advanced therapies for haematological cancer patients.
CAR-T Cell Therapy | 13/04/2026 | By News Bureau | 157
Biocytogen Grants Licence for RenNano Platform to Taisho Pharmaceutical
Biocytogen licenses its RenNano platform to Taisho Pharmaceutical to advance fully human heavy chain-only antibody discovery, supporting in-vivo screening and downstream research.
CAR-T Cell Therapy | 31/03/2026 | By News Bureau | 102
Oricell Therapeutics Raises USD 70M in Series C1 to Advance CAR-T Therapies for Solid Tumors
The funding will accelerate global expansion and clinical development of Oricell’s CAR-T pipeline, including its lead hepatocellular carcinoma programme Ori-C101.
CAR-T Cell Therapy | 13/01/2026 | By News Bureau | 271
Bristol Myers Squibb Acquires Orbital Therapeutics
The acquisition of Orbital Therapeutics by Bristol Myers Squibb includes OTX-201, an investigational next-generation CAR T-cell therapy designed to reprogramme cells in vivo with potential best-in-class profile for autoimmune diseases.
CAR T-cell Therapy | 13/10/2025 | By Dineshwori | 265
Made Scientific, Hemogenyx Partner to Advance CAR-T Cell Therapy for AML
Made Scientific and Hemogenyx Pharmaceuticals have announced a technology transfer and manufacturing partnership to advance HG-CT-1, an autologous CAR-T cell therapy for acute myeloid leukaemia (AML).
CAR-T Cell Therapy | 09/09/2025 | By Mrinmoy Dey | 158
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy